Leukotrienes as mediators of airway obstruction and inflammation in asthma
- 1 November 1995
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 25 (s2) , 50-54
- https://doi.org/10.1111/j.1365-2222.1995.tb00422.x
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects.Thorax, 1993
- Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissuesFEBS Letters, 1993
- Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthmaJournal of Allergy and Clinical Immunology, 1992
- Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthmaJournal of Allergy and Clinical Immunology, 1992
- Peptide leukotrienes: current status of researchJournal of Medicinal Chemistry, 1991
- Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjectsThe Lancet, 1991
- Characteristics of formation and further metabolism of leukotrienes in the chopped human lungBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Inhaled lysine-aspirin as a bronchoprovocation procedure in aspirin-sensitive asthma: Its repeatability, absence of a late-phase reaction, and the role of histamineJournal of Allergy and Clinical Immunology, 1989
- Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological EffectsScience, 1987
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980